Campbell & Co Investment Adviser’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
VCM
VPM
Campbell & Co Investment Adviser's HALO Position: Q1 2026 in Review
Campbell & Co Investment Adviser sold out of Halozyme (HALO) in Q1 2026, closing a stake of 6,347 shares — an estimated $427K sold.
Campbell & Co Investment Adviser first reported a position in HALO in Q2 2013 and held it in 21 quarters. The position peaked at $6.51M in Q1 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.
- Campbell & Co Investment Adviser reported no remaining Halozyme position as of Q1 2026 after selling out during the quarter.
- Campbell & Co Investment Adviser sold 6,347 Halozyme shares in Q1 2026, an estimated $427K.
- Campbell & Co Investment Adviser first reported a position in Halozyme in Q2 2013 and held it in 21 quarters.
- Campbell & Co Investment Adviser's Halozyme position peaked at $6.51M in Q1 2025.
- 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.
Based on Campbell & Co Investment Adviser's 13F filing for Q1 2026, filed 15 May 2026.